| Health / Medical Topics |
Monoclonal Antibody L6
A murine IgG2a monoclonal antibody with potential antineoplastic activity. Monoclonal antibody L6 binds to the L6 antigen, a cell surface glycoprotein overexpressed in many carcinomas, and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against L6-expressing tumor cells. This agent may be conjugated with various toxins in order to target their cytotoxic activity to tumor cells expressing the L6 antigen. (NCI Thesaurus)
YOU MAY ALSO LIKE
Monoclonal recombinant antibody J591 (mAb HuJ591) recognizes the extracellular domain of prostate specific membrane antigen (PSMA), a cell surface peptidase highly expressed…
An anti-carcinoembryonic antigen (anti-CEA) murine monoclonal immunoglobulin G (IgG) with potential antineoplastic activity. CEA is overexpressed in several cancer cell types,…
A rat monoclonal antibody that inhibits Epidermal Growth Factor Receptor (EGFR), targeting tumor cells expressing the wild-type EGFR and EGFRvIII.
A humanized monoclonal antibody directed against the pancreatic cancer antigen MUC1 with potential antineoplastic activity. Monoclonal antibody HuPAM4 (mAb HuPAM4) binds to…
A humanized monoclonal antibody directed against vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. HuMV833 has been shown to decrease the…
A substance being studied in the treatment of myelodysplastic syndromes and some types of leukemia. It binds to CD33, a protein on…
